Redhill Biopharma Ltd (NASDAQ:RDHL)

Delayed Data
As of 3:59pm ET
 +0.07 / +12.73%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 2 analysts offering 12-month price forecasts for Redhill Biopharma Ltd have a median target of 11.00, with a high estimate of 11.00 and a low estimate of 11.00. The median estimate represents a +1,674.19% increase from the last price of 0.62.

Analyst Recommendations

The current consensus among 1 polled investment analysts is to Buy stock in Redhill Biopharma Ltd. This rating has held steady since October, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Aug 25

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 33.33%
Growthannually 96.19%


Growthquarterly 17.91%
Growthannually 3.09%
Key to the earnings and sales forecast charts.